Angiotensin converting enzyme inhibitors and risk of lung cancer-Reference-Cited by-同舟云学术

Angiotensin converting enzyme inhibitors and risk of lung cancer

Published:2021-04-30 Issue:17 Volume:100 Page:e25714
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Batais Mohammed,Almigbal Turky,Alotaibi Khalid,Alodhayani Abdulaziz,Alkhushail Abdullah,Altheaby Abdulrahman,Alhantoushi Mashhor,Alsaad Saad,Dalbhi Sultan Al,Alghamdi Yasser

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference51 articles.

1. The renin-angiotensin system and cancer: old dog, new tricks;George;Nat Rev Cancer,2010

2. The renin-angiotensin system and malignancy;Ager;Carcinogenesis,2008

3. Angiotensin inhibition and malignancies: a review;Rosenthal;J Hum Hypertens,2009

4. Targeting the renin-angiotensin system to improve cancer treatment: implications for immunotherapy;Pinter;Sci Transl Med,2017

5. Angiotensin-converting enzyme and its association with outcome in lung cancer;Rømer;Br J Cancer,1981

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers;Journal of Hypertension;2024-08-08

2. Classical and nonclassical effects of angiotensin-converting enzyme: How increased ACE enhances myeloid immune function;Journal of Biological Chemistry;2024-06

3. Beyond blood pressure, fluid and electrolyte homeostasis – Role of the renin angiotensin aldosterone system in the interplay between metabolic diseases and breast cancer;Acta Physiologica;2024-05-21

4. An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancer;JTCVS Open;2024-04

5. Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence;European Heart Journal;2024-03-05